Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 30, 2026, 9:30 AM EST

Biostax Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-0.97-1.48-1.16-0.74-0.89-2.84
Net Income
-1.87-2.36-3.543.591.59-3.4
Earnings Per Share
-0.02-0.03-0.100.383.33-7.42
EPS Growth
----88.60%--

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
00.030.153.140.010
Total Debt
1.161.130.73.792.845.55
Net Cash (Debt)
-1.16-1.1-0.55-0.65-2.83-5.54
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.02-0.07-5.95-12.11

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
0.13-0.41-0.58-0.23-0.19-0
Capital Expenditures
------
Free Cash Flow
0.13-0.41-0.58-0.23-0.19-0
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PE Ratio
---0.404.30-
PS Ratio
------